RIVOPHARM - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79195512
Serial Number
79195512
Registration Number
5234473
Word Mark
RIVOPHARM
Status
700 - Registered
Status Date
2017-07-04
Filing Date
2016-07-26
Registration Number
5234473
Registration Date
2017-07-04
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2017-04-18
Attorney Name
Law Office Assigned Location Code
M40
Employee Name
MURRAY, DAVID T
Statements
Goods and Services
Pharmaceutical preparations, both prescription and over-the-counter, namely, pharmaceutical preparations for peptic ulcer and gastrooesophageal reflux disease (GORD), propulsives, intestinal anti-infectives, intestinal anti-inflammatory agents, oral pharmaceutical preparations for lowering blood glucose, Vitamin A and D, mixed vitamin preparations consisting of vitamins A and D, vitamin and mineral preparations for medical use, vitamin C in the nature of ascorbic acid mixed vitamin preparations consisting partially of Vitamin C, calcium supplements, mineral supplements, anti-thrombotic agents, intravenous solutions, cardiac glycosides, class I and class III anti-arrhythmics, pharmaceutical preparations for cardiac stimulation excluding cardiac glycosides, Vasodilators used in the treatment of cardiac diseases, anti-adrenergic agents, pharmaceutical preparations for acting on arteriolar smooth muscle, Beta blocking agents, Selective calcium channel blockers, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors combined with other pharmaceutical preparations, anti-fungals for systemic use, anti-infectives and antiseptics, excluding those combined with corticosteroids, oxytocics, plain corticosteroids for systemic use, thyroid preparations, anti-thyroid preparations, tetracyclines preparations, macrolides, lincosamides and streptogramins, aminoglycoside antibacterials, quinolone antibacterials, antimycotics for systemic use, direct acting antivirals, immune sera, bacterial vaccines, alkylating agents, anti-metabolites, plant alkaloids, cytotoxic antibiotics, hormone antagonists and related agents, namely, anti-estrogens, anti-androgens and enzyme inhibitors, immunosuppressive agents, antiinflammatory and antirheumatic preparations, non-steroids in the nature of butylpyrazolidines, acetic acid derivatives, oxicams, propionic acid derivatives, fenamates, Coxibs, muscle relaxants, peripherally acting agents in the nature of curare alkaloids and choline derivatives, antigout preparations, analgesics and antipyretics preparations, anti-migraine preparations, anti-epileptic preparations, anti-cholinergic agents, dopaminergic agents, anti-psychotics, anxiolytics, hypnotics and sedatives, antidepressants, parasympathomimetics, agents for use against amoebiasis and other protozoal diseases, anti-malarial preparation, adrenergics, inhalant anesthetics, adrenergics for systemic use, antihistamines for systemic use, diuretic agents
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2016-11-07
Primary Code
005
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Jeffrey B. Sladkus
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
0892492
International Registration Date
2006-07-25
International Publication Date
2016-11-03
International Renewal Date
2026-07-25
Auto Protection Date
2018-05-03
International Status
001 - Request for extension of protection established
International Status Date
2016-11-03
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event DateEvent Description
2016-11-03SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
2016-11-07NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2016-11-07ASSIGNED TO EXAMINER
2016-11-08NON-FINAL ACTION WRITTEN
2016-11-09NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2016-11-11APPLICATION FILING RECEIPT MAILED
2016-11-15REFUSAL PROCESSED BY MPU
2016-11-15NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2016-12-09REFUSAL PROCESSED BY IB
2017-03-01TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2017-03-01ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2017-03-02TEAS RESPONSE TO OFFICE ACTION RECEIVED
2017-03-02CORRESPONDENCE RECEIVED IN LAW OFFICE
2017-03-02TEAS/EMAIL CORRESPONDENCE ENTERED
2017-03-03ASSIGNED TO LIE
2017-03-06DATA MODIFICATION COMPLETED
2017-03-06APPROVED FOR PUB - PRINCIPAL REGISTER
2017-03-10LAW OFFICE PUBLICATION REVIEW COMPLETED
2017-03-29NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-03-29NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2017-03-29NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2017-04-18PUBLISHED FOR OPPOSITION
2017-04-18OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2017-07-04REGISTERED-PRINCIPAL REGISTER
2017-10-04FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2017-10-10FINAL DISPOSITION PROCESSED
2017-10-10FINAL DISPOSITION NOTICE SENT TO IB
2017-10-13NOTIFICATION PROCESSED BY IB